Critical Care Clinics 2003: Vol 19 Index

21 Pages·2003·3.5 MB·English

CRITICAL
CARE
CLINICS
Crit Care Clin 19 (2003) 827-846
Cumulative Index 2003
Volume 19
January SUBSPECIALTY CRITICAL CARE, PART I, pages | —154
April SUBSPECIALTY CRITICAL CARE, PART II, pages 155-336
July PEDIATRIC CRITICAL CARE, pages 337-604
October GERIATRIC CRITICAL CARE, pages 605-836
Vote: Page numbers of article titles are in boldface type.
A mechanical ventilation in, 700—702
Abdominal injuries prone positioning in, 703
in children. 558—559 surfactant therapy in, 703-704
ventilator-associated, 698
Abdominal wounds ventilator-induced, 698
open
in plastic and reconstructive Acute renal failure (ARF), 565-577. See
surgery, 93-96 Renal failure, acute
: b 6 98 Pp anticoagulation therapy for, 570—571
ABG analysis. See Arterial blood gas Salinas ake S65 SOK
(ABG) analysis. CRRT for
ACCM. See American College of Critical Care access for, 567 568
Medicine (ACCM) initiation of, 571-572
machinery for, 568
Acute lung injury (ALI), 693-712 membranes for, 569
clinical presentation of, 694 solutions for, 569—570
coagulation/thrombosis in, 698 hemofiltration for, 567
defined, 693 nutrition in, 572—573
endothelial injury in, 696—697 outcome in. 573574
epidemiology of, 694 pathophysiology of, 565-566
epithelial injury in, 696-697 renal replacement therapy for
fibrosing alveolitis, 698—699 options for, 566—567
molecular genetics and, 588—590
mortality rates for, 694—695 Acute respiratory distress syndrome (ARDS)
neutrophil-dependent lung injury in, causes of, 468—469
697-698 clinical presentation of, 694
outcomes of, 695-696 coagulation/thrombosis in, 698
pathology/pathogenesis of, 696-699 defined, 693 —694
prognosis of, 695 described, 468
resolution of, 699-700 endothelial injury in, 696-697
risk factors for, 694 epidemiology of, 694
treatment of, 700-704 epithelial injury in, 696—697
anti-inflammatory agents in, 704 fibrosing alveolitis, 698-699
antioxidants in, 704 in the elderly, 693-712
corticosteroids in, 704 mortality rates for, 694-695
fluid management in, 702—703 neutrophil-dependent lung injury in,
general supportive measures 697-698
in, 700 outcomes of, 695-696
inhaled nitric oxide in, 703 pathology/pathogenesis of, 696-699
0749-0704/03/$ — see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/S0749-0704(03)00086-1
Cumulative Index / Crit Care Clin 19 (2003) 827-846
pediatric multiple organ failure and American College of Veterinary Emergency
treatment of, 430 and Critical Care (ACVECC), 316
prevalence of, 469
American Geriatrics Society (AGS), 751,
prognosis of, 695
757, 761
resolution of, 699—700
risk factors for, 694 Amiodarone
surfactant causing, 468-470 for pediatric cardiac arrest, 350
surfactant for, 470—471 Analgesic(s)
treatment of, 700-704 for obese surgical patients, 26—27
anti-inflammatory agents in, 704
antioxidants in, 704 Anastomosis(es)
corticosteroids in, 704 cavopulmonary
fluid management in, 702—703 bidirectional
general supportive measures in, 700 in single-ventricle physiology,
inhaled nitric oxide in, 703 405-407
total
mechanical ventilation in, 700—702
prone positioning in, 703 in single-ventricle physiology,
408-410
surfactant therapy in, 703—704
ventilator-associated, 698 Anesthesia/anesthetics
ventilator-induced, 698 in hip surgery, 34—35
local
ACVECC. See American College of Veterinary for pain in the elderly in ICU, 763
Emergency and Critical Care (ACVECC). perioperative
Adrenal insufficiency in the elderly, 641-656
pediatric septic shock and adverse postoperative
treatment of, 426 outcomes
related to, 641—650
anesthetic technique effects
as factor in outcome of elderly cancer on, 644-645,
patients in ICU, 659-660 646-647, 649
morbidity associated with,
Aging. See also Elderly; Geriatric 643-644
critical care. mortality related to, 641-643
respiratory function effects on, 259-260 neurologic effects on,
vascular responsiveness to, 256—259 648 —6 49
preoperative testing effects
Airway(s)
on, 650—652
complications of
prophylactic therapy effects
heart and lung transplantation and,
on, 645-646, 647,
221-222
649-650
in head and neck patients pulmonary effects of, 646
management of, 84
Angina
Airway obstruction Ludwig’s
in plastic and reconstructive surgery, otolaryngologic critical care for,
102-103 66—67
ALI. See Acute lung injury (ALI). Angiography
CT
Alpha-methylnorepinephrine spiral
in cardiopulmonary-cerebral resuscitation in venous thromboembolism,
in children, 353 194-195
magnetic resonance
Alveolitis in venous thromboembolism,
fibrosing pulmonary
in ALI and ARDS, 698—699 in venous thromboembolism,
195-196
American Academy of Pain Medicine, 751
Anthrax
American College of Chest Physicians, 416 delivery of, 281—286
American College of Critical Care Medicine Antiarrhythmic agents
(ACCM), 757 for pediatric cardiac arrest, 350
Cumulative Index / Crit Care Clin 19 (2003) 827-846
Antibiotic(s) Asthma
for obese surgical patients, 26 surfactant levels in, 467
for pediatric septic shock, 429
Atrial fibrillation
Antibiotic/heparin flush in geriatric critical care, 684—685
in central venous catheter occlusion
prevention, 502 Atrial septum
in single-ventricle physiology, 397
Anticoagulant(s)
for ARF, 570-571 Autopsy(ies)
for obese surgical patients, 26 demographic and cultural factors in,
for venous thromboembolism, 196 631-635
complications of, 197—198
in cardiopulmonary-cerebral resuscitation Azotemia
in children, 354 prerenal, 234
Prerenal azotemia
Anti-inflammatory drugs
for ALI and ARDS, 704
nonsteroidal
B
for pain in the elderly in ICU, 763
Bariatric surgery, 13—17
Antioxidant(s) combined procedures in, 16 l 7
for ALI and ARDS, 704 complications of, 17—19
in cardiopulmonary-cerebral resuscitation malabsorptive procedures in, 14—15
in children, 354 restrictive procedures in, 15—16
Antithrombin III replacement therapy Bariatric surgical patients
for sepsis-related coagulation critical care of, 11-32
dysfunction, 453 perioperative triage of, 19-20
Antithrombotic agents Bidirectional cavopulmonary anastomosis
continuous infusion of in single-ventricle physiology, 405—407
in central venous catheter occlusion
prevention, 502—503 Biochemical markers
intermittent instillation of in cardiopulmonary-cerebral resuscitation
in central venous catheter occlusion in children, 353-354
prevention, 502 Biologic agents
systemic
delivery of, 281—303. See also specific
in central venous catheter occlusion agents, e.g., Anthrax.
prevention, 503—504 anthrax, 281 —286
Anxiety, 782-784 B agents, 303-304
clinical features of, 782 botulinum, 294—296
diagnosis of, 783 plague, 286—289
epidemiology of, 782 smallpox, 297-300
evaluation of, 783—784 tularemia, 289-294
in the critically ill elderly, 818-819 viral hemorrhagic fever, 300
treatment of, 783—784 potential, 280
Apoptosis blocking Biologic attack
in cardiopulmonary-cerebra! resuscitation vs. natural epidemic, 280-281
in children, 355 Bioterrorism
ARDS. See Acute respiratory distress biologic agents in
syndrome (ARDS) delivery of, 281—303
potential, 280
ARF. See Acute renal failure (ARF). critical care’s role in, 304—306
Arrhythmia(s) natural epidemic vs. biologic attack,
in geriatric critical care, 683-686 280-281
Arterial blood gas (ABG) analysis Bladder reconstructive surgery, 2—4
in venous thromboembolism, 190
Bleeding
Ascites variceal
pathophysiology of, 163 pathophysiology of, 163
Cumulative Index / Crit Care Clin 19 (2003) 827-846
Blood pressure management interventions for, 337—339
after cardiopulmonary- phases of, 337
cerebral resuscitation
in children, 351-352 Cardiac infections
in pediatric ICU, 482—485
Bloodstream infections
in pediatric ICU, 477—478 Cardiac output
in single-ventricle physiology, 401
Blunt aortic injury
in children, 557—558 Cardiopulmonary resuscitation (CPR)
benefits of, 816-817
Bone marrow transplantation
burdens of, 816-817
as factor in outcome of elderly cancer
in critically ill elderly
patients in ICU, 662-664
controversial issues in, 813-814,
Botulinum 816-817
delivery of, 294—296 open-chest
in children, 346
Brain injury
traumatic. See Traumatic brain injury. Cardiopulmonary-cerebral resuscitation
in children, 337-365. See also Cardiac
Breathing
arrest, in children.
during cardiopulmonary-
alpha-methylnorepinephrine in, 353
cerebral resuscitation
anticoagulant therapy in, 354
in children, 344
antioxidants in, 354
Buffer solutions apoptosis blocking in, 355
for pediatric cardiac arrest, - biochemical markers in, 353-354
blood pressure management after,
351-352
C breathing during, 344
circulation during, 344
Calcium
circumferential vs. focal sternal
for pediatric cardiac arrest, 350
compressions in, 346
Cancer clinical trials of, 356
hepatocellular cold aortic flush in, 355
liver transplantation candidates compression-to-ventilation ratio
with, 158—159 during, 344—345
in the elderly in ICU defibrillators in
described, 657-658 automated external, 348
outcomes of, 657-675 monophasic vs. biphasic, 348
age as factor in, 659-660 duty cycle in, 345-346
bone marrow transplantation ECMO -~ cardiopulmonary
in, 662—664 oxygenation, 347
hematologic malignancies in, educational initiatives after, 352
660-662 excitotoxicity modulation in,
mechanical ventilation in, 354-355
664-668 glucose control after, 351
predictors of, 659-670 hibernation induction in,
scoring systems in, 669-670 informed consent for
exception to, 356
Cardiac allograft vasculopathy
interventions after, 351]
lung and heart transplantation and,
low-flow
220-221
interventions during,
Cardiac arrest 341 —343
in children. See also Cardiopulmonary- necrosis blocking in 355
=
cerebral resuscitation, in children. nitric oxide in, 5
epidemiology of, 339-341 no-flow
treatment of, 348-351 interventions during,
antiarrhythmic agents in, 350 341-343
buffer solutions in, 350—351 open-chest CPR, 346
calcium in, 350 optimization of defibrillation
vasopressors in, 348—349 in, 348
Cumulative Index / Crit Care Clin 19 (2003) 827-846
optimization of hemodynamics in prevention of, 501—504
mechanical devices in, risk factors for, 494-496
346-347 treatment of, 504—509
optimization of provider catheter maintenance in, 504
performance after, 352 catheter removal in, 504
real-time feedback after, 352—353 catheter replacement in, 504
registry development related to, 356 future directions in, 510—511
research related to, 356 heparinization in, 505—506
room air in, 354 intermittent thrombolytic
SAPO in, 355-356 therapy in, 507
temperature management after, 351 interventional radiology
in, 509
Cardiovascular issues low molecular weight heparin
in geriatric critical care, 677-691.
in, 506—507
See also Geriatric critical care, oral anticoagulation therapy
cardiovascular issues in
in, 508
Cardiovascular system outcome after, 509-510
in the elderly thrombectomy in, 509
critical illness effects on, 255 thrombolytic continuous infu-
in vascular surgery patients sion therapy in, 508
complications of, 117 vena cava filter in, 508-509
venous stasis and, 495
Cat(s) vessel wall injury and, 495
critical care for, 317—320
Cerebral blood flow dysregulation
Catheter(s)
after traumatic brain injury, 532-533
central venous
historical background of, 491 Cerebral swelling
hypothrombogenic after traumatic brain injury
in central venous catheter occlusion in infants and children, 53 538
prevention, 501 treatment of, 539-540
Cavopulmonary anastomosis Cerebrovascular accidents (CVAs)
bidirectional in vascular surgery patients, 119
in single-ventricle physiology,
405 —407 Chest radiography
total in venous thromboembolism, 190
in single-ventricle physiology,
Children
408—410
abdominal injuries in, 558—559
Cell death/apoptosis blunt aortic injury in, 557 558
programmed cardiac arrest in. See Cardiac arrest,
after traumatic brain injury, 536—537 in children.
cardiopulmonary-cerebral resuscitation
Central venous catheter(s)
historical background of, 491 in, 337-365. See also
Cardiopulmonary-cerebral
Central venous catheter occlusion resuscitation, in children.
described, 491 —492 esophageal injuries in, 557
thrombosis resulting from, 491-516 IACS in, 558—559
assessment of, 499 ICU for. See Pediatric ICU.
catheter composition and, 494-495 missed hollow viscus injuries in, 559
catheter duration and, 496 myocarditis in, 367—393. See also
catheter-to-vessel ratio and, 495 Myocarditis, in children.
classification of, 491—493 nosocomial infections in
diagnosis of, 497—499 in pediatric ICU, 475-489. See
incidence of, 496 also Nosocomial infections, in
infusate and, 495 pediatric ICU
morbidity related to, 499-501 terrorist attack effects on, 559-560
mortality related to, 501 thoracic injuries in, 555—558
pathophysiology of, 494 trauma in, 553-563. See also Trauma,
patient factors in, 495 in children.
Cumulative Index / Crit Care Clin 19 (2003) 827-846
Chronic obstructive pulmonary pneumococcal vaccine for,
disease (COPD) 742-743
costs related to, 713-714 prevention of, 742
described, 713 resource use for, 732—733
in the elderly, 713-727 severity assessment in,
acute exacerbations of, 714—716 735-737
management of treatment of, 738—741
end-of-life care in ICU in, empiric antimicrobial therapy
in, 739-740
722-723
mechanical ventilation in, in nonresponding
719-721 patients, 741
weaning from, 721 respiratory management in,
palliative care in, 722—723 740-741
pharmacologic, 716—719 supportive measures in, 738
outcome of, 721—722
Compression(s)
prognosis of, 721-722
circumferential vs. focal sternal
smoking and, 714
during cardiopulmonary-
prevalence of, 713
cerebral resuscitation
societal impact of, 713-714
in children, 346
Circulation Compression-to-ventilation ratio
during cardiopulmonary- during cardiopulmonary-
cerebral resuscitation cerebral resuscitation
in children, 344 in children, 344—345
Clinical Practice Parameters for Computed tomography (CT) angiography
Hemodynamic Support in Pediatric spiral
Neonatal Patients in Septic Shock, 416 in venous thromboembolism,
194-195
Coagulation
dysfunction of Conduction disorders
in MODS, 443-460 in geriatric critical care, 683-686
in sepsis, 443-460. See also
Sepsis, coagulation Consent
dysfunction in. informed. See Informed consent.
Continual renal replacement therapy (CRRT)
Coagulation/thrombosis
in ALI and ARDS, 698 for ARF
access for, 567-568
Coagulopathy(ies) initiation of, 571—572
fulminant hepatic failure and, 162 machinery for, 568
membranes for, 5
Cold aortic flush solutions for, 569—570
in cardiopulmonary-cerebral resuscitation vasopressor and, 573~
in children, 355
COPD. See Chronic obstructive pulmonary
Communication
disease (COPD).
at end of life, 814-816
in end-of-life care in critically ill elderly Coronary syndromes
population, 796—802 acute
in geriatric critical care, 679-681
Community-acquired pneumonia
in the elderly, 729-748 Corticosteroid(s)
causes of, 734-735 for ALI and ARDS, 704
clinical presentation of, 735
CPR. See Cardiopulmonary
costs related to, 732—733
resuscitation (CPR).
defined, 729
described, 729 Critical care
diagnostic evaluation of, 738 emergency medicine and, 271-278. See
incidence of, 730—731 also Emergency medicine, critical
limitation of care for, 741-742 care and.
long-term outcome of, 733-734 otolaryngologic, 55—72. See also
mortality related to, 731-732 Otolaryngologic critical care.
Cumulative Index / Crit Care Clin 19 (2003) 827-846
Critical illness incidence of
in the elderly among ill populations, 775
epidemiology of, 605-617 management of, 777—779
CRRT. See Continual renal replacement outcomes of, 777
pain vs.
therapy (CRRT)
in the elderly in ICU, 761
Culture precipitating factors for, 775—777
definitions related to, 622—626 predisposing factors for, 775—777
in United States prevalence of, 775
critical care issues related to,
Delivered oxygen
619-639 manipulation of
autopsies, 631—635
in single-ventricle physiology,
death and dying, 631-635
401-405
described, 619-621
end-of-life decisions, Demographics
626-630 in United States
informed consent, 626—630 critical care issues related to,
organ donation, 631 —635 619-639
patient autonomy, 626-630 autopsies, 631-635
death and dying, 631-635
CVAs. See Cerebrovascular accidents (CVAs).
described, 619-621
Cystic fibrosis organ donation, 631-635
surfactant levels in, 467—468
Deoxyribonucleic acid (DNA)
in gene structure, 579-581
D Depression, 779-782
clinical features of, 779-780
D-dimer levels
diagnosis of, 780—781
in venous thromboembolism, 190—191 epidemiology of, 780
Death evaluation of, 781—782
pronouncement of in the critically ill elderly, 818—819
in end-of-life care in critically ill risk factors for, 780
elderly population, 802 —803 treatment of, 781—782
Death and dying Dextran
demographic and cultural factors in, in plastic and reconstructive surgery, 102
631-635
DIC. See Disseminated intravascular coagula-
Deep venous thrombosis tion (DIC)
diagnosis of, 193-194 Disseminated intravascular coagulation (DIC)
Defibrillation defined, 444—445, 446
optimization of pathogenesis of, 445
in cardiopulmonary- pediatric septic shock and
cerebral resuscitation treatment of, 428
in children, 348 sepsis-induced
diagnosis of, 445
Defibrillator(s) fibrinolytic pathway in, 449-450
automated external
for cardiopulmonary-cerebral DNA. See Deoxyribonucleic acid (DNA).
resuscitation
Dog(s)
in children, 348 critical care for, 317—320
monophasic vs. biphasic
for cardiopulmonary- Drug(s)
cerebral resuscitation and renal failure, 243-245
in children, 348 for acute exacerbations of COPD,
716-719
Delirium, 771-779
for pain in the elderly in ICU, 761-762
clinical features of, 772—773
described, 771-772 Duty cycle
diagnosis of, 773-775 in cardiopulmonary-cerebral resuscitation
in vascular surgery patients, 120 in children, 345—346
834 Cumulative Index / Crit Care Clin 19 (2003) 827-846
Dysfunctional natural anticoagulant system in ICU
sepsis-related coagulation dysfunction end-of-life care for, 790
and, 448-449 mechanical ventilation in, 261
pain in
Dysrhythmia(s)
in ICU, 749-776
in vascular surgery patients, 118
assessment of, 754
barriers to, 759
E causes of, 752-754
delirium vs. pain, 761
ECG. See Electrocardiography (ECG). descriptors of, 754—756
ECMO. See Extracorporeal membrane in cognitively impaired
oxygenation (ECMO). patients, 756—759
in special populations,
Ejaculation
756-759
retrograde
intensity of, 755
in vascular surgery patients, 120
management of
Elderly. See also Aging; Geriatric critical care. barriers to, 750, 759
acute lung injury in, 693-712 chronic pain, 763
ARDS in, 693-712 local anesthetics in, 763
cancer in nonopioid analgesics in,
in ICU 762-763
outcomes of, 657-675 nonpharmacologic,
outcomes of. See also
763-767
Cancer, in the NSAIDs in, 763
elderly in ICU,
opioid analgesics in, 762
outcomes of. pharmacologic,
cardiovascular function in, 256—258
761—767
stress effects on, 258-259
topical agents in, 763
cardiovascular structure in, 256
pain pattern, 755-756
community-acquired pneumonia in,
perception of pain, 760
729-748. See also Community-
prevalence of, 749-750
acquired pneumonia, in the elderly.
COPD in, 713-727. See also Chronic quality of pain, 754
obstructive pulmonary disease research on, 750
(COPD), in the elderly site of, 755
critical care in, 253-270. See also neuropathic
Geriatric critical care. physiology of, 751—752
controversial issues in, 811-825 perioperative anesthesia in, 641-656.
anxiety, 818-819 See also Anesthesia/anesthetics,
CPR, 813-814, 816-817 perioperative, in the elderly.
depression, 818—819 pharmacologic issues in, 263
euthanasia, 817—818 pneumonia in, 260
forgoing treatment in ICU, Electrocardiography (ECG)
819-820 in venous thromboembolism, 190
patients’ preferences
Electrolyte(s)
multicenter studies of,
in pediatric septic shock management, 429
811-813
planning ahead, 821 Embolic disease
satisfaction with care, lung and heart transplantation and, 221
820-821 Embolism
critical illness in
fat
chronic, 613-614
hip surgery and, 37-38
epidemiology of, 605-617
pulmonary
quality of life of, 612-613
diagnosis of, 194
resources for
hip surgery and, 36
use of, 614-615
survival of, 607-612 Emergency medicine
critically ill critical care and, 271-278
end-of-life care in, 789-810. See current status of, 271-276
also End-of-life care, in crit- strategies for improvement,
ically ill elderly population. 276-277
Cumulative Index / Crit Care Clin 19 (2003) 827-846
Encephalopathy(ies) Euthanasia
hepatic controversial issues related to, 817—818
fulminant hepatic failure+caused by,
Evidence-based medicine
160-161
practical approach to, 517—529. See also
End of life Ventilator(s), management protocol
communication at, 814-816 for, development of
End-of-life care. See also Intensive care Excitotoxicity
unit (ICU) after traumatic brain injury, 533—534
in critically ill elderly population, modulation of
789-810 in cardiopulmonary-
candidates for, 790 cerebral resuscitation
communication in, 796—802 in children, 354—355
costs of, 790—791
Extracorporeal membrane oxygenation
death pronouncement in, 802
(ECMO) —cardiopulmonary oxygenation
decisional capacity assessment
in cardiopulmonary-cerebral resuscitation
in, 797
in children, 347
ethics of, 795—796
family conferences in, 798-802 F
goal setting in, 798
holistic issues in, 802—804 Faces Pain Scale (FPS), 756
informed consent in, 797
Family conferences
interdisciplinary model for,
in end-of-life care in critically ill elderly
791-795
life support withdrawal in, 804—807 population, 798—802
mechanical ventilation withdrawal Fasciitis
in, 804—807 necrotizing
palliative care in plastic and reconstructive
principles of, 791 surgery, 96—97
physician’s role in, 803
Fat embolism
transitions to, 798
hip surgery and, 37—38
with COPD, 722-723
Fibrin sheath, 493
End-of-life decisions
cultural perspective on Fibrosing alveolitis
in ALI and ARDS, 698—699
Endothelial injury
Fibrosis(es)
sepsis and
cystic
and tissue factor activation,
447-448 surfactant levels in,
idiopathic pulmonary
Enzyme(s) surfactant levels in,
restriction Fick equation, 398
and polymorphisms, 581—583
Fluid management
Epidemic for ALI and ARDS, 702
natural
vs. biologic attack, 280-281 Fluid overload
pathophysiology of, 163
Epiglottitis
acute Foal(s)
otolaryngologic critical care for, neonatal
critical care of, 3
62-65
Epinephrine Free-tissue transfer
for pediatric cardiac arrest, 348-349 in plastic and reconstructive surgery,
97-102
Esophageal injuries
in children, 557 Fulminant hepatic failure
cardiovascular system disarrangements
Ethical issues and, 161
in end-of-life care in critically ill elderly clinical manifestations of, 160
population, 795—796 coagulopathy and, 162
Cumulative Index / Crit Care Clin 19 (2003) 827-846
hepatic encephalopathy and, 160—161 H
infections and, 162 Head and neck patients
liver transplantation for, 159-162 airway management in, 84
nutritional status and, 162 complications in, 75—79
pathophysiology of, 160 conditions in, 80-84
renal failure and, 161 critical care of, 73-90
respiratory system disturbance and, 161 general issues in, 85
Furosemide in ICU, 74—75
for acute renal failure, 238
Heart
infections of
in pediatric ICU, 482—485
G Heart transplantation
Gastric bypass complications of
complications of, 17-19 airway-related, 22] —222
indications for, 13 cardiac allograft vasculopathy,
220-221
Gastrointestinal complications
embolic disease, 221
lung and heart transplantation and,
gastrointestinal, 222-223
979 ee §
infections, 216—217
Gastrointestinal system ischemia-reperfusion injury,
in vascular surgery patients 217-219
complications of, 121—122 pleural, 222
rejection, 219-220
Gene(s)
critical care issues in, 209-231
regulation of, 579-581
donor selection for, 212—213
structure of, 579-581 indications for, 210
DNA in, 579-581
postoperative period care in,
RNA in, 580
215-216
Genetic tools preoperative period care in, 213-214
in critical illness, 588 prognosis of, 223—225
recipient selection for, 210—2
Genomics, 585—586 surgical techniques in, 214—2
Geriatric critical care, 253-270. See also
HELP. See Hospitalized Elderly Longitudinal
Aging; Elderly. Project (HELP).
cardiovascular issues in, 255—259,
677-691 Hematologic malignancies
acute coronary syndromes, as factor in outcome of elderly cancer
679-681 patients in ICU, 660—662
arrhythmias, 683 —686
atrial fibrillation, 684—685 Hemofiltration
conduction disorders, 683—686 for ARF, 567
valvular disease, 687-689
Hemorrhage
ventricular arrhythmias, 685-686
in vascular surgery patients, 115—116
ventricular dysfunction, 681—683
demographic considerations in, 253-255 Heparin
multisystem considerations in, 261 —263 for venous thromboembolism, 197
outcome considerations in, 263—266 in central venous catheter occlusion
respiratory considerations in, 259-261 prevention, 502—503
low molecular weight
Glucose control
in central venous catheter occlusion
after cardiopulmonary-
management, 506—507
cerebral resuscitation
in children, 351 Heparinization
in central venous catheter occlusion
Gynecology
management, 505-506
obstetrics and
critical care, 127-149. See also Hepatic encephalopathy
Obstetrics and gynecology, fulminant hepatic failure caused by,
critical care. 160-161